| SYS | | r040570 |
|---|
| LBL | | ^^^^^naa^^22^^^^^^^^450^ |
|---|
| 005 | | 20130619105503.7 |
|---|
| 100 | | $a 20070222a2006 m y0sloc0103 ba |
|---|
| 101 | 0- | $a eng $d eng |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a Induction of drug resistance in embryonal rhabdomyosarcoma treated with conventional chemotherapy is associated with HLA class I increase $f J. Prados ... [et al.] |
|---|
| 215 | | $c obr., tab. |
|---|
| 320 | | $a Res. angl. |
|---|
| 320 | | $a Bibliogr. odkazy |
|---|
| 463 | -1 | $1 001 sllk_un_cat*sg000148_2006_006_003 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 53, no. 3 (2006), s. 226-231 $1 210 $a Bratislava $c VEDA, vydavateľstvo Slovenskej akadémie vied |
|---|
| 541 | 1- | $a Indukcia liekovej rezistencie pri embryonálnom rabdomyosarkóme liečenom konvenčnou chemoterapiou je spojená so zvýšením HLA I. triedy $z slo |
|---|
| 606 | 1- | $a rabdomyosarkóm embryonálny $x farmakoterapia $x genetika $2 mesh $3 sllk_un_auth*d018233 $9 . |
|---|
| 606 | 1- | $3 sllk_un_auth*d018432 $a rezistencia lieková mnohopočetná $x genetika $9 . $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d015395 $a antigény histokompatibilné I. triedy $x analýza $9 . $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d018435 $a ATP-viažuci kazetový transportér, podrodina B $9 . $2 mesh |
|---|
| 606 | 2- | $a gény MDR $2 mesh $3 sllk_un_auth*d019450 $9 . |
|---|
| 606 | 2- | $a imunohistochémia $2 mesh $3 sllk_un_auth*d007150 $9 . |
|---|
| 606 | 2- | $3 sllk_un_auth*d000970 $a antineoplastiká $9 . $2 mesh |
|---|
| 610 | 2- | $a chemoterapia |
|---|
| 610 | 2- | $a HLA antigény |
|---|
| 675 | | $a 616-006.2.36-085:615.277 $v 2. $z slo |
|---|
| 701 | -1 | $a Prados $b J. $3 sllk_un_auth*p0030346 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain |
|---|
| 701 | -1 | $a Melguizo $b C. $3 sllk_un_auth*p0030345 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain |
|---|
| 701 | -1 | $a Fernández $b J. E. $3 sllk_un_auth*p0047116 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain |
|---|
| 701 | -1 | $a Carrillo $b E. $3 sllk_un_auth*p0030349 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain |
|---|
| 701 | -1 | $a Marchal $b J.A. $3 sllk_un_auth*p0030347 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain |
|---|
| 701 | -1 | $a Boulaiz $b H. $3 sllk_un_auth*p0030350 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain |
|---|
| 701 | -1 | $a Martínez $b A. $3 sllk_un_auth*p0047117 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain |
|---|
| 701 | -1 | $a Rodriguez-Serrano $3 sllk_un_auth*p0047118 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain |
|---|
| 701 | -1 | $a Aránega $b A. $3 sllk_un_auth*p0030636 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain |
|---|
| 801 | -0 | $a SK $b BA006 $c 20070222 $g AACR2 |
|---|
